首页> 外文会议>International Symposium on Ocular Pharmacology and Therapeutics >In Vitro Activation of Steroid Receptors in Corneal Epithelial Cells Using a Novel Anti-inflammatory Liposomal Formulation
【24h】

In Vitro Activation of Steroid Receptors in Corneal Epithelial Cells Using a Novel Anti-inflammatory Liposomal Formulation

机译:使用新型抗炎脂质体制剂在角膜上皮细胞中对类固醇受体的体外活化

获取原文

摘要

Unpreserved liposome-based formulations were loaded with the anti-inflammatory agent medroxyprogesterone (mdx). We aimed at determining the in vitro activation of steroid receptors in corneal epithelial cells after exposure to mdx-loaded liposomes (mdx-lipo). For that purpose, the Human Corneal Epithelial (HCE) cell line was exposed to formulations for 1 h. Exposure of HCE cells to mdx-lipo leads to an activation of glucocorticoid and progesterone receptors and a reduction in proliferation rate. Therefore, we consider this novel liposome-based formulation potentially useful as anti-inflammatory drug delivery system.
机译:将未验证的脂质体的配方用抗炎剂中吡酯(MDX)加载。 我们旨在在暴露于MDX加载的脂质体之后确定角膜上皮细胞中类固醇受体的体外活化(MDX-LIPO)。 为此目的,人体角膜上皮(HCE)细胞系暴露于1小时的制剂。 HCE细胞暴露于MDX-LIPO导致糖皮质激素和孕酮受体的激活和增殖率的降低。 因此,我们认为这种基于新的脂质体的配方可能是抗炎药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号